Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 7, 2017; 23(25): 4559-4568
Published online Jul 7, 2017. doi: 10.3748/wjg.v23.i25.4559
Published online Jul 7, 2017. doi: 10.3748/wjg.v23.i25.4559
Figure 4 Rosuvastatin attenuated the expression of 8-OHdG and NOX1, but not of NOX2, in a dextran sodium sulphate-induced colitis model.
A: 8-OHdG expression in colon sections from DSS-induced colitis mice treated with and without rosuvastatin by immunohistochemistry. 8-OHdG expression was attenuated in the rosuvastatin-treated group. Magnification × 10; B: NOX1 and NOX2 expression in colon sections from DSS-induced colitis mice treated with and without rosuvastatin by immunofluorescence. NOX1 expression was attenuated in the rosuvastatin-treated group. NOX2 expression levels were not different in DSS-induced colitis mice and control mice. Magnification × 10. DSS: Dextran sodium sulphate; 8-OHdG: 8-hydroxy-2’-deoxyguanosine; NOX: NADPH oxidase.
- Citation: Shin SK, Cho JH, Kim EJ, Kim EK, Park DK, Kwon KA, Chung JW, Kim KO, Kim YJ. Anti-inflammatory and anti-apoptotic effects of rosuvastatin by regulation of oxidative stress in a dextran sulfate sodium-induced colitis model. World J Gastroenterol 2017; 23(25): 4559-4568
- URL: https://www.wjgnet.com/1007-9327/full/v23/i25/4559.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i25.4559